GlassScriptPhysician profile
Arwyn Taffs
NPI 1881035038
$3,021.09
in general payments reported to CMS, 2019-2025
14 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,102 · 2022: $1,315 · 2023: $234 · 2024: $97.00 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,146.67 | 2021-2022 | |
| Amgen INC. | $198.41 | 2023-2025 | Otezla, Otezla, Tavneos |
| Pfizer INC. | $108.30 | 2021-2024 | |
| Tactile Systems Technology INC | $104.96 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $90.57 | 2021-2025 | Eliquis |
| Lilly USA, LLC | $77.21 | 2025 | Taltz |
| Horizon Therapeutics Plc | $61.73 | 2023 | Krystexxa |
| Boston Scientific Corporation | $50.76 | 2021 | |
| Medtronic, INC. | $39.79 | 2023 | Abre |
| Siemens Medical Solutions USA, INC. | $38.25 | 2022 | |
| Glaxosmithkline, LLC. | $36.92 | 2024 | Benlysta |
| Abbvie INC. | $30.33 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $21.85 | 2024 | |
| Daiichi Sankyo INC. | $15.34 | 2023 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arwyn Taffs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.